dc.creator | Vignoni, Mariana | |
dc.creator | de Alwis Weerasekera, Hasitha | |
dc.creator | Simpson, Madeline J. | |
dc.creator | Phopase, Jaywant | |
dc.creator | Mah, Thien Fah | |
dc.creator | Griffith, May | |
dc.creator | Alarcon, Emilio I. | |
dc.creator | Scaiano, Juan C. | |
dc.date.accessioned | 2016-04-08T17:28:13Z | |
dc.date.available | 2016-04-08T17:28:13Z | |
dc.date.created | 2016-04-08T17:28:13Z | |
dc.date.issued | 2014-04 | |
dc.identifier | Vignoni, Mariana; de Alwis Weerasekera, Hasitha; Simpson, Madeline J.; Phopase, Jaywant; Mah, Thien Fah ; et al.; LL37 peptide@silver nanoparticles: combining the best of the two worlds for skin infection control; Royal Society of Chemistry; Nanoscale; 6; 11; 4-2014; 5725-5728 | |
dc.identifier | 2040-3372 | |
dc.identifier | http://hdl.handle.net/11336/5086 | |
dc.description.abstract | Capping silver nanoparticles with LL37 peptide eradicates the antiproliferative effect of silver on primary skin cells, but retains the bactericidal properties of silver nanoparticles with activities comparable to silver nitrate or silver sulfadiazine. In addition, LL37 capped silver nanoparticles have anti-biofilm formation activity. | |
dc.language | eng | |
dc.publisher | Royal Society of Chemistry | |
dc.relation | info:eu-repo/semantics/altIdentifier/url/http://pubs.rsc.org/en/content/articlelanding/2014/nr/c4nr01284d#!divAbstract | |
dc.relation | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1039/c4nr01284d | |
dc.rights | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | Nanoparticles | |
dc.subject | Skin Infection | |
dc.subject | Ll37 Peptide | |
dc.title | LL37 peptide@silver nanoparticles: combining the best of the two worlds for skin infection control | |
dc.type | info:eu-repo/semantics/article | |
dc.type | info:ar-repo/semantics/artículo | |
dc.type | info:eu-repo/semantics/publishedVersion | |